Lab Test

Human Herpesvirus 6 by PCR

Human herpesvirus 6 PCR, HHV-6, HHV6, Roseola, Herpesvirus-6 Human DNA DetectR

Test Codes

Serum: EPIC: LAB1230194, Viracor: 6510, Whole Blood: EPIC: LAB1230195, Viracor: 6516, Bone Marrow: EPIC: LAB1230191, Viracor: 6504

Department

Send Outs

Specimen Collection Criteria

Collect (preferred specimen): One Lavender-top EDTA tube.

Also acceptable: One plain Red-top tube, or Bone Marrow in EDTA Lav Tube.

Physician Office/Draw Specimen Preparation

Centrifuge to separate serum Transfer serum to a plastic transport tube and keep at room temperature (20-26°C or 68-78.8°F). Maintain Bone Marrow and whole blood  at room temperature (20-26°C or 68-78.8°F) prior to transport.

Preparation for Courier Transport

Transport: 2.0 mL serum,  Bone Marrow or Whole Blood at room temperature (20-26°C or 68-78.8°F). (Minimum: 0.5 mL)

Rejection Criteria

Specimens not collected and processed as indicated.

In-Lab Processing

Centrifuge to separate serum from cells. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F). Maintain Bone Marrow and whole blood at room temperature (20-26°C or 68-78.8°F) prior to transport.

Transport: 2.0 mL serum, Bone Marrow or Whole Blood at room temperature (20-26°C or 68-78.8°F). (Minimum: 0.5 mL)

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): 96 hours
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unknown

Specimen Storage in Department Prior to Disposal:

Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.

Laboratory

Sent to Eurofins/Viracor Laboratory in Lenexa, KS.

Performed

Monday – Saturday.
Results available in 1-2 days.

Reference Range

See report.

Test Methodology

Quantitative Polymerase Chain Reaction (PCR).

Interpretation

By report.

Clinical Utility

This assay aids in the diagnosis of roseola infantum (infection subitum) and other HHV-6 infections.

Clinical Disease

HHV-6 is the causative agent of roseola. Roseola is characterized by the abrupt onset of a high fever which is followed in 2-4 days by erthematous maculopapular rash that lasts for 1-2 days. Roseola lesions are macular or papular and never become vesicular like the lesions associated with VZV or HSV. Lesions typically appear on the neck and back and then spread to the abdomen and thighs. The syndrome is self-limiting, but convulsions associated with high fever can cause permanent neurologic injury. Atypical roseola can occur in the absence of rash. (1)

Epidemiology

HHV-6 infections are common, and the virus has been found throughout the world. HHV-6 infections can occur in all age groups, but they are usually acquired before three years of age. HHV-6 is the causative agent of roseola in children. Roseola is a common infection of infancy, and the peak incidence of roseola occurs between the ages of 6 and 18 months. Infants less than 6 months are thought to be protected by maternal antibodies. Adults who become infected are often only mildly symptomatic. (1)

Incubation Period

5-15 days. (1)

Transmission

Transmission of HHV-6 is poorly understood. It is thought that the virus is transmitted after contact with oral secretions. (1)

Reference

  1. Locatelli G., Santoro F., Veglia F., Gobbi A., Lusso P and Malnati MS. 2000. Real-time quantitative PCR for human herpesvirus-6 DNA. J. Clin.Microbiology. 38: 4042-4048.

CPT Codes

87533

Contacts

Last Updated

8/23/2024

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.